Luminex Corporation Receives Clearance from Health Canada for xTAG(TM) Respiratory Viral Panel

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it has received clearance from Health Canada for its xTAG(TM) Respiratory Viral Panel (RVP). xTAG RVP is a unique, groundbreaking test that, from one patient sample, simultaneously detects the 18 respiratory viruses and subtypes that are responsible for the majority of respiratory viral infections.

Source: Luminex